Market Overview
Global Milk Allergy Clinical Trials Review market was valued at USD 987 million in 2024 and is projected to reach USD 1.21 billion by 2032, exhibiting a CAGR of 3.0% during the forecast period. This growth is driven by increasing awareness and prevalence of cow’s milk allergy (CMA), which affects approximately 2-3% of infants and young children globally, according to epidemiological studies.
Milk allergy clinical trials focus on evaluating diagnostic methods such as skin prick tests, blood allergen-specific IgE tests, oral food challenges, and elimination diets to identify and manage CMA.
These trials aim to develop safer and more effective treatments while addressing the rising demand for solutions to this common pediatric condition. Recent advancements in immunotherapy approaches, including oral and sublingual desensitization protocols, are shaping the market landscape.
Market size
USD 987 million in 2024
CAGR of 3.0% CAGR 2032 USD 1.21 billion by 2032
By Type
Skin Prick Tests Dominate the Market Due to Widespread Clinical Adoption and Cost-
Effectiveness
The market is segmented based on type into:
Skin Prick Tests
Blood Allergen Specific IgE Tests
Subtypes: Fluorescent Enzyme Immunoassay, Radioallergosorbent Test, and others
Oral Food Challenge
Food Elimination Diet
By Application
Management of CMPA Segment Leads Due to Rising Prevalence of Cow's Milk
Protein Allergy in Infants
The market is segmented based on application into:
Immediate Treatment
Portable Neuromonitoring Device Market
Subtypes: Emergency care, Allergy management
Management of CMPA
Subtypes: Nutritional management, Immunotherapy
Our Key Players
Nestle Health Science (Switzerland)
FrieslandCampina (Netherlands)
Mead Johnson Nutrition (U.S.)
Abbott Laboratories (U.S.)
Danone SA (France)
https://www.24lifesciences.com/download-
sample/2056/milk-allergy-clinical-trials-review-marketmarket
https://www.24lifesciences.com
